genOway Société anonyme (EPA:ALGEN)

Market Cap	22.13M -21.1%
Revenue (ttm)	20.96M -23.9%
Net Income	928.00K -49.3%
EPS	n/a
Shares Out	9.22M
PE Ratio	23.85
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	9,542
Average Volume	10,319
Open	2.420
Previous Close	2.400
Day's Range	2.380 - 2.500
52-Week Range	2.100 - 3.500
Beta	0.40
RSI	44.13
Earnings Date	Apr 2, 2026

About genOway Société anonyme

genOway Société anonyme, a biotechnology company, engages in the development and commercialization of custom genetically modified mouse, rat, and cell line models worldwide. It produces customized mouse models, such as knockout (KO) and knockin (KI) mouse models; customized rat models, including constitutive and conditional KO, point mutation KI, and quick KI rat models; and customized cell lines, such as constitutive and inducible KO, point mutation KI, reporter KI, quick KI, and KI cell lines. The company also offers humanized immune checkpoi...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 1999
• Employees: 148
• Stock Exchange: Euronext Paris
• Ticker Symbol: ALGEN

Financial Performance

In 2025, genOway Société anonyme's revenue was 20.96 million, a decrease of -23.88% compared to the previous year's 27.53 million. Earnings were 928,000, a decrease of -49.31%.